Top News

Mar 02, 2017
The Mutual Recognition Agreement will allow FDA and EU inspectors to recognize each other’s work and avoid the duplication of drug inspections.
Feb 16, 2017
The Patent Trial and Appeal Board ruled in favor of the Broad Institute, allowing the institution to keep patents for its CRISPR-Cas9 gene-editing technology.
Feb 16, 2017
PhRMA submits comments to the The Office of the United States Trade Representative encouraging protection of US innovation in foreign markets.
Feb 14, 2017
Evaluate and BioPharm International highlight the antibody-based therapeutics that may have 2017 launch dates in the United States.
Feb 13, 2017
EvaluatePharma and BioPharm International highlight the antibody-based therapeutics that may gain United States Regulatory approval in 2017.
Feb 13, 2017
Drug companies are pushing Congress to action on funding for FDA programs and staff to expedite drug reviews and approvals.
Feb 10, 2017
A total of 166 biotech executives penned an open letter expressing concern over President Donald Trump’s executive order on immigration.
Feb 07, 2017
Aggressive petitioning by ViroPharma kept a generic equivalent to Vancocin off the market for more than two years.
Feb 01, 2017
A change in the tax code could help the company create more jobs in the United States, while fewer FDA regulations could help reduce drug prices, according to Pfizer CEO Ian Read.
Jan 31, 2017
Trump met with pharma manufacturers and makes a statement focused on domestic manufacturing, FDA approvals, and drug pricing.
native1_300x100
lorem ipsum